open access

Vol 30, No 4 (2023)
Original Article
Submitted: 2021-07-02
Accepted: 2021-10-24
Published online: 2021-10-26
Get Citation

Comprehensive appraisal of cardiac motion artefact in optical coherence tomography

Miao Chu12, Carlos Cortés34, Lili Liu51, Miguel Ángel Martínez-Hervás-Alonso2, Bernd Reisbeck62, Ruiyan Zhang5, Shengxian Tu1, Juan Luis Gutiérrez-Chico5237
·
Pubmed: 34708865
·
Cardiol J 2023;30(4):543-555.
Affiliations
  1. Med-X Research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, China
  2. Cardiology Department, Campo de Gibraltar Health Trust, Algeciras (Cádiz), Spain
  3. Klinikum Frankfurt (Oder), Frankfurt (Oder), Germany
  4. Miguel Servet University Hospital, Zaragoza, Spain
  5. Department of Cardiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
  6. CardioCare Heart Center, Marbella, Spain
  7. DRK Klinikum Westend, Berlin, Germany

open access

Vol 30, No 4 (2023)
Original articles — Interventional cardiology
Submitted: 2021-07-02
Accepted: 2021-10-24
Published online: 2021-10-26

Abstract

Background: The relation between cardiac motion artefact (CMA) in optical coherence tomography
(OCT) and the phases of cardiac cycle is unclear.

Methods: Optical coherence tomography pullbacks containing metallic stents were co-registered with
angiography and retrospectively analyzed. The beginning of three phases, namely ejection, rapid-inflow
and diastasis, was identified in angiography. Rotation, shortening, elongation and repetition were
qualitatively labelled as CMA artefacts. Platforms with coaxial longitudinal connectors (ML8 and
Magmaris) entered a quantitative sub-study, consisting of measuring the length of their connector at
the beginning of each phase.

Results: A total of 261 stents (127 patients) were analyzed, including 105 stents for quantitative
sub-study. CMA was detected in 61 (23.4%) stents: rotation in 6 (2.3%), shortening in 50 (19.2%),
elongation in 51 (19.5%) and repetition in 12 (4.6%). Shortening was always observed during ejection
phase, while elongation and repetition were always observed during rapid-inflow. Rotation occurred in
both ejection and rapid-inflow phases, while no artefact was reported during diastasis. Longitudinal
connectors measured in early ejection phase and in early rapid-inflow phase were shorter and longer,
respectively, than those measured in diastasis, irrespective of the presence of CMA in the qualitative
assessment.

Conclusions: Cardiac motion artefact is prevalent in OCT studies, but shortening and elongation of
vascular structures occur during early ejection and during early rapid-inflow, respectively, to a greater
or lesser extent in all cases. Diastasis is free of CMA and hence the period in which longitudinal measurements
can be more accurately quantified.

Abstract

Background: The relation between cardiac motion artefact (CMA) in optical coherence tomography
(OCT) and the phases of cardiac cycle is unclear.

Methods: Optical coherence tomography pullbacks containing metallic stents were co-registered with
angiography and retrospectively analyzed. The beginning of three phases, namely ejection, rapid-inflow
and diastasis, was identified in angiography. Rotation, shortening, elongation and repetition were
qualitatively labelled as CMA artefacts. Platforms with coaxial longitudinal connectors (ML8 and
Magmaris) entered a quantitative sub-study, consisting of measuring the length of their connector at
the beginning of each phase.

Results: A total of 261 stents (127 patients) were analyzed, including 105 stents for quantitative
sub-study. CMA was detected in 61 (23.4%) stents: rotation in 6 (2.3%), shortening in 50 (19.2%),
elongation in 51 (19.5%) and repetition in 12 (4.6%). Shortening was always observed during ejection
phase, while elongation and repetition were always observed during rapid-inflow. Rotation occurred in
both ejection and rapid-inflow phases, while no artefact was reported during diastasis. Longitudinal
connectors measured in early ejection phase and in early rapid-inflow phase were shorter and longer,
respectively, than those measured in diastasis, irrespective of the presence of CMA in the qualitative
assessment.

Conclusions: Cardiac motion artefact is prevalent in OCT studies, but shortening and elongation of
vascular structures occur during early ejection and during early rapid-inflow, respectively, to a greater
or lesser extent in all cases. Diastasis is free of CMA and hence the period in which longitudinal measurements
can be more accurately quantified.

Get Citation

Keywords

tomography, optical coherence, artefact, percutaneous coronary intervention, coronary heart disease, stents

Supp./Additional Files (1)
Supplementary Video 1. Backward movement of the optical source in a paradigmatic case of repetition artefact, using zoomed co-registration with angiography.
Download
1MB
About this article
Title

Comprehensive appraisal of cardiac motion artefact in optical coherence tomography

Journal

Cardiology Journal

Issue

Vol 30, No 4 (2023)

Article type

Original Article

Pages

543-555

Published online

2021-10-26

Page views

2493

Article views/downloads

549

DOI

10.5603/CJ.a2021.0137

Pubmed

34708865

Bibliographic record

Cardiol J 2023;30(4):543-555.

Keywords

tomography
optical coherence
artefact
percutaneous coronary intervention
coronary heart disease
stents

Authors

Miao Chu
Carlos Cortés
Lili Liu
Miguel Ángel Martínez-Hervás-Alonso
Bernd Reisbeck
Ruiyan Zhang
Shengxian Tu
Juan Luis Gutiérrez-Chico

References (10)
  1. Okamura T, Onuma Y, Garcia-Garcia HM, et al. High-speed intracoronary optical frequency domain imaging: implications for three-dimensional reconstruction and quantitative analysis. EuroIntervention. 2012; 7(10): 1216–1226.
  2. Farooq V, Gogas BD, Okamura T, et al. Three-dimensional optical frequency domain imaging in conventional percutaneous coronary intervention: the potential for clinical application. Eur Heart J. 2013; 34(12): 875–885.
  3. Cecchetti L, Wang T, Hoogendoorn A, et al. In-vitro and in-vivo imaging of coronary artery stents with Heartbeat OCT. Int J Cardiovasc Imaging. 2020; 36(6): 1021–1029.
  4. Prati F, Cera M, Ramazzotti V, et al. Safety and feasibility of a new non-occlusive technique for facilitated intracoronary optical coherence tomography (OCT) acquisition in various clinical and anatomical scenarios. EuroIntervention. 2007; 3(3): 365–370.
  5. Gutiérrez-Chico JL, Cortés C, Schincariol M, et al. A formula to calculate the contrast volume required for optimal imaging quality in optical coherence tomography with non-occlusive technique. Cardiol J. 2018; 25(5): 574–581.
  6. Tu S, Westra J, Yang J, et al. FAVOR Pilot Trial Study Group. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the international multicenter FAVOR pilot study. JACC Cardiovasc Interv. 2016; 9(19): 2024–2035.
  7. Cortes C, Chu M, Schincariol M, et al. Identification of the type of stent with three-dimensional optical coherence tomography: the SPQR study. EuroIntervention. 2021; 17(2): e140–e148.
  8. Guagliumi G, Costa MA, Sirbu V, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial. Circulation. 2011; 123(3): 274–281.
  9. Gutiérrez-Chico JL, van Geuns RJ, Koch KT, et al. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first. EuroIntervention. 2011; 7(6): 711–722.
  10. Gutiérrez-Chico JL, Wykrzykowska J, Nüesch E, et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography. Circ Cardiovasc Interv. 2012; 5(1): 20–9, S1.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl